Globally recognized leader in early-phase oncology clinical development and experimental therapeuticsStrengthens strategic ...
Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the ...
Modern OCT devices can look inside the eye without a scalpel - but they do not always capture everything that matters. Some ...
When Vera Therapeutics in-licensed atacicept from Merck KGaA about six years ago, patients with IgA nephropathy (IgAN) had no ...
Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...
Tech Xplore on MSN
Programmable metasurface generates dozens of holograms at once
Over the past few decades, engineers have developed various devices that can create holograms, three-dimensional (3D) or ...
Modern OCT devices can look inside the eye without a scalpel - but they do not always capture everything that matters. Some critical information is ...
The experience of the GT3 Sport Cabriolet is only enhanced by the power-operated roof, but the big challenge will likely be ...
Top line data readout expected in late Q3/early Q4; INFORM-MS trial is a randomized, double-blind, placebo-controlled Phase ...
Morning Overview on MSN
A nasal spray reversed signs of brain aging in early tests, and a patent is already filed
Researchers at Texas A&M University reported that two intranasal doses of extracellular vesicles derived from human neural ...
A new approach for identifying signs of hidden awareness in people who cannot speak or move after severe brain injury has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results